PotBotics Takes Aim at the Vaporizer Market with RYAH
Ryan Allway February 26th, 2019 Vaporizers have become ubiquitous across many parts of the country. You can’t walk more than ten minutes in Los Angeles or Denver without coming across someone vaping on the sidewalk. Not surprisingly, the market for vaporizers is projected to exceed $60 billion by 2025,... Read more
Halo Labs Signs Bulk Biomass Procurement and Bulk Extract Supply Agreement with Cannus Partners in California
Ryan Allway February 26th, 2019 CATHEDRAL CITY, Calif. & TORONTO–(BUSINESS WIRE)– EXPECTED TO ADD AN ADDITIONAL US$1MM PER MONTH IN REVENUE Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTC: AGEEF) is pleased to announce it has entered into a two-part agreement with Cannus Partners Inc. (“Cannus”) for... Read more
Aleafia Becomes First Cannabis Stock to Top TSX Venture 50 Performance Rankings
Ryan Allway February 22nd, 2019 Uncategorized The TSX Venture exchange has become a popular place for cannabis companies to list their shares, particularly after Canada legalized recreational cannabis last year, but 2019 was the first year that a cannabis company topped its annual performance rankings. Aleafia Health Inc. (TSX-V:... Read more
Helix TCS, Inc. to Webcast Live at VirtualInvestorConferences.com February 20th
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not... Read more
BNN Bloomberg Identifies Indiva as Rapidly Growing in the Cannabis Sector
Ryan Allway February 15th, 2019 News, Top News /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./ LONDON, ON, Feb. 15, 2019 /CNW/ – Indiva Limited (the “Company” or “Indiva“) (TSX:NDVA) (US:NDVAF):  On BNN Bloomberg this Saturday February 16 and Sunday February 17, 2019... Read more
Acquisition Of GoodFellas Will Include Proprietary Brand called Simple, includes the Simple Kit(TM)
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not... Read more
3 Sixty Secure Signs Agreements with Leading Licensed Producers
Ryan Allway February 5th, 2019 Exclusive, News, Top News Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis last year. The upcoming legalization of edibles and other forms of cannabis could further accelerate growth as... Read more
Transcanna Provides Investors with Exposure to Ancillary Cannabis Businesses
Ryan Allway January 25th, 2019 News, Top Story The global cannabis industry is projected to reach more than $150 billion by 2025, according to Grand View Research, driven by legalization across a growing number of countries. While most investors are focused on cannabis cultivators and retailers, these companies still... Read more
48North Provides Update on its 100-acre Outdoor Farm Application
Ryan Allway January 24th, 2019 TORONTO, Jan. 24, 2019 /CNW/ – 48North Cannabis Corp. (“48North” or the “Company”)  (TSXV:NRTH) is pleased to announce that it has submitted its site evidence package to Health Canada in connection with its license application, submitted in October 2018, for the Company’s 100-acre outdoor... Read more
Pascal Biosciences Commences Cannabinoid Testing of Human Volunteers and Patients
Ryan Allway January 24th, 2019 VANCOUVER, British Columbia, and SEATTLE, Jan. 24, 2019 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the testing of cannabinoids in human subjects for its immune stimulatory program in cancer. Furthermore, the Company... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )